Disclaimer: This image is entirely AI-generated and is a product of artificial intelligence. Any resemblance to actual persons, whether living or deceased, is purely coincidental and unintentional.
Uploaded 10 hours ago
Duration: 0h 4m 51s
Abbott Bets On Semaglutide Boom
Abbott will exclusively distribute and market Extensior in the country, becoming the second company to secure sole distribution rights for Novo's semaglutide portfolio in India, after Emcure Pharma.
Uploaded by: Rediff Video Desk on Sat, 28 Feb 2026 11:53:10 +0530
Views: 38
Tags: India, Novo Nordisk, Abbott, Ozempic, Emcure Pharma, Semaglutide Boom, Wegovy, Mounjaro, Extensior, Lilly
© 2026